Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by jojomarchon Dec 29, 2017 8:50am

89 Views

Post# 27243946

RE:RE:Nice deal

Good catch EnriqueSuave . So this company gets breakthrough status and then can apply for a marketing application . The CEO of SGEN declines to provide a timeline for the drug's approval path ...smart guy . The science at TLT is great , maybe even unique , if that's the case smart industry leaders should recognize this and open their wallet . Maybe RW should give a call to Greenhill & co .

CHEERS

Bullboard Posts

This junior mining stock offers billions in market exposure